Thursday, Dec. 22, 2022

 Thursday, Dec. 22, 2022, was a miserable day for the market as a whole. But Paradigm Press Group’s science-and-wealth specialist Ray Blanco noticed something interesting: “I saw plenty of relative strength in the SPDR S&P Biotech ETF (NYSE: XBI).

“Around noon, XBI was able to reverse off its losses and climb to just around breakeven.